Friday, May 15, 2020

Itolizumab use for Covid-19 encouraging, says Biocon

Biocon has got permission from the Drug Controller General of India to use Itolizumab in moderate to severe patients with Covid-19 complications https://ift.tt/3dMuxf5 https://ift.tt/eA8V8J

No comments:

Post a Comment

Docs: Israeli AI chip startup Hailo is pursuing an urgent IPO via a SPAC merger at a valuation of less than $500M; it was last valued at $1.2B in 2024 (Meir Orbach/CTech)

Meir Orbach / CTech : Docs: Israeli AI chip startup Hailo is pursuing an urgent IPO via a SPAC merger at a valuation of less than $500M; ...